Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Stock

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|December 13, 2022
Changes over time in patient visits and continuity of care among graduating cohorts of family physicians in 4 Canadian provincesDavid Rudoler, Sandra Peterson, David Stock, et al.
Current Oncology (Toronto, Ont.)|June 26, 2024
Real-World Safety of Niraparib for Maintenance Treatment of Ovarian Cancer in CanadaQi Guan, Suriya J Aktar, Reka E Pataky, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|December 26, 2025
Calcitonin gene-related peptide inhibitor use in 2018-2023: a retrospective cohort study across six Canadian provincesJason R Randall, Karen J B Martins, Huong Luu, et al.
Annals of Family Medicine|March 27, 2023
Declining Comprehensiveness of Services Delivered by Canadian Family Physicians Is Not Driven by Early-Career PhysiciansM Ruth Lavergne, David Rudoler, Sandra Peterson, et al.
Canadian Family Physician Medecin De Famille Canadien|August 15, 2023
Changes in comprehensiveness of services delivered by Canadian family physicians: Analysis of population-based linked data in 4 provincesM Ruth Lavergne, David Rudoler, Sandra Peterson, et al.
Antimicrobial Agents and Chemotherapy|May 2, 2012
In vitro antiviral characteristics of HIV-1 attachment inhibitor BMS-626529, the active component of the prodrug BMS-663068Beata Nowicka-Sans, Yi-Fei Gong, Brian McAuliffe, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|December 13, 2022
Changes over time in patient visits and continuity of care among graduating cohorts of family physicians in 4 Canadian provincesDavid Rudoler, Sandra Peterson, David Stock, et al.
Current Oncology (Toronto, Ont.)|June 26, 2024
Real-World Safety of Niraparib for Maintenance Treatment of Ovarian Cancer in CanadaQi Guan, Suriya J Aktar, Reka E Pataky, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|December 26, 2025
Calcitonin gene-related peptide inhibitor use in 2018-2023: a retrospective cohort study across six Canadian provincesJason R Randall, Karen J B Martins, Huong Luu, et al.
Annals of Family Medicine|March 27, 2023
Declining Comprehensiveness of Services Delivered by Canadian Family Physicians Is Not Driven by Early-Career PhysiciansM Ruth Lavergne, David Rudoler, Sandra Peterson, et al.
Canadian Family Physician Medecin De Famille Canadien|August 15, 2023
Changes in comprehensiveness of services delivered by Canadian family physicians: Analysis of population-based linked data in 4 provincesM Ruth Lavergne, David Rudoler, Sandra Peterson, et al.
Antimicrobial Agents and Chemotherapy|May 2, 2012
In vitro antiviral characteristics of HIV-1 attachment inhibitor BMS-626529, the active component of the prodrug BMS-663068Beata Nowicka-Sans, Yi-Fei Gong, Brian McAuliffe, et al.
Pageof 5